Using an anti-human polyclonal antibody (which we confirmed to be IGLL5-specific using siRNA knockdown experiments; Additional file1: Figure S3A-B), we compared three samples each from areas exhibiting early and advanced CAD (diffuse intimal thickening and fibroatheroma, respectively). The gene discussed is IGLL5; the disease is coronary artery disorder.